Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients

Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients

ObjectiveThere is still a lack of highly sensitive methods for monitoring recurrence of colorectal cancer patients after liver metastasis surgery. The aim of this study was to evaluate the prognostic value of tumor-naive ctDNA detection after resection of colorectal liver metastases (CRLM).MethodsPa...

Full description

Bibliographic Details
Main Authors:	Huiqin Jiang, Fei Huang, Yihui Yang, Xinning Chen, Minna Shen, Chunyan Zhang, Baishen Pan, Beili Wang, Wei Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Oncology
Subjects:	minimal residual disease (MRD) circulating tumor DNA (ctDNA) colorectal cancer liver metastases (CRLM) next-generation sequencing – NGS recurrence
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1153685/full

Similar Items

Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
by: Lemei Zhu, et al.
Published: (2023-08-01)

Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
by: Lissa Wullaert, et al.
Published: (2023-10-01)

Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcomaResearch in context
by: Yiwei Fu, et al.
Published: (2024-07-01)

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients
by: Huu Thinh Nguyen, et al.
Published: (2022-12-01)

Expression of plasma methylated Septin9 gene and its clinical significance in patients with gastric cancer
by: CHEN Xinning, JIANG Huiqin, YANG Yihui, YU Qian, ZHANG Chunyan, WANG Beili, PAN Baishen, GUO Wei
Published: (2023-02-01)

Feasibility of ctDNA in detecting minimal residual disease and predicting recurrence for colorectal cancer liver metastases
by: Jennifer A. Kalil, et al.
Published: (2024-10-01)

Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer
by: Naing Lin Shan, et al.
Published: (2024-12-01)

Comparison of detection methods and analysis of influencing factors of somatic mutation in plasma of metastatic colorectal cancer patients
by: CHEN Xinning , HUANG Fei , SHEN Minna , YANG Yihui , WANG Beili , GUO Wei
Published: (2021-03-01)

Minimal residual disease guided radical chemoradiotherapy combined with immunotherapy after neoadjuvant immunochemotherapy followed by adjuvant immunotherapy for esophageal squamous cell cancer (ECMRD-001): a study protocol for a prospective cohort study
by: Hesong Wang, et al.
Published: (2024-01-01)

Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer
by: Kezhong Chen, et al.
Published: (2023-07-01)

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
by: Daan C. L. Vessies, et al.
Published: (2022-07-01)

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
by: Jan M. van Rees, et al.
Published: (2023-01-01)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
by: Xiaoxu Fang, et al.
Published: (2022-10-01)

Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next‐generation sequencing
by: Huiqin Jiang, et al.
Published: (2023-07-01)

Detection of Metastatic Tumor Cells in the Bone Marrow Aspirate Smears by Artificial Intelligence (AI)-Based Morphogo System
by: Pu Chen, et al.
Published: (2021-09-01)

Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma
by: Xiao-Bo Wu, et al.
Published: (2022-07-01)

Epigenetic liquid biopsies for minimal residual disease, what’s around the corner?
by: Andrew D. Johnston, et al.
Published: (2023-04-01)

Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients
by: Ana Barbosa, et al.
Published: (2021-09-01)

Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
by: Ran Zhong, et al.
Published: (2023-05-01)

The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers
by: Ronan J. Kelly, et al.
Published: (2025-02-01)

Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
by: Keerthi Ranganathan, et al.
Published: (2024-09-01)

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
by: Ana Jiménez-Ubieto, et al.
Published: (2023-06-01)

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
by: Ana Jiménez-Ubieto, et al.
Published: (2023-08-01)

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
by: Ana Jiménez-Ubieto, et al.
Published: (2024-01-01)

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
by: Cathy Zhou, et al.
Published: (2018-11-01)

Methodology established for the detection of circulating tumor DNA by hybridization capture
by: Xumei Yao, et al.
Published: (2022-09-01)

Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents
by: Markus G. Seidel, et al.
Published: (2022-08-01)

From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
by: Steven P. Rowe, et al.
Published: (2018-10-01)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
by: Andrew A. Davis, et al.
Published: (2019-12-01)

Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches
by: David W. Cescon, et al.
Published: (2022-02-01)

Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling–informed personalized monitoring assay
by: Thomas Powles, et al.
Published: (2023-07-01)

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
by: Estela Sánchez-Herrero, et al.
Published: (2022-07-01)

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
by: Patrizio Giacomini, et al.
Published: (2023-10-01)

An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis
by: Yaozhong Zhang, et al.
Published: (2024-01-01)

Dynamics of cell-free tumor DNA correlate with early MRI response during chemoradiotherapy in rectal cancer
by: Kerstin Clasen, et al.
Published: (2024-11-01)

Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy
by: Hua Cao, et al.
Published: (2020-04-01)

Network approach in liquidomics landscape
by: Daniele Santini, et al.
Published: (2023-08-01)

Dynamics of Minimal Residual Disease in Neuroblastoma Patients
by: Suguru Uemura, et al.
Published: (2019-06-01)

Bibliometric analysis of global research trends and prospects on circulating tumor DNA in colorectal cancer
by: Jing Pang, et al.
Published: (2024-11-01)

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
by: Sudeepto Saha, et al.
Published: (2022-02-01)